SUNHO MULTI-GINSENG TABLET, NEW FORMULA Ástralía - enska - Department of Health (Therapeutic Goods Administration)

sunho multi-ginseng tablet, new formula

bio solution pty ltd - salvia miltiorrhiza, quantity: 60 mg (equivalent: salvia miltiorrhiza, qty 60 mg); panax notoginseng, quantity: 122 mg (equivalent: panax notoginseng, qty 122 mg); panax quinquefolius, quantity: 128 mg (equivalent: panax quinquefolius, qty 128 mg) - tablet, uncoated - excipient ingredients: sodium starch glycollate; colloidal anhydrous silica; calcium hydrogen phosphate dihydrate; magnesium stearate - traditionally used in chinese medicine to enhance/promote/physical endurance/capacity/stamina ; traditionally used in chinese medicine to helps enhance/promote general health and wellbeing ; traditionally used in chinese medicine to helps enhance/promote healthy blood circulation ; traditionally used in chinese medicine to helps enhance/improve/promote blood circulation to the peripheral areas of the body (legs, hands and feet) ; traditionally used in chinese medicine to maintain/support cardiovascular system health ; traditionally used in chinese medicine to orexigenic/improve/promote healthy appetite ; traditionally used in chinese medicine to adaptogen/help body adapt to stress ; traditionally used in chinese medicine to decrease/reduce/relieve symptoms of mild anxiety ; traditionally used in chinese medicine to maintain/support mental concentration/focus/clarity ; traditionally used in chinese medicine to decrease/reduce/relieve sleeplessness ; traditionally used in chinese medicine to male toni

EXTINE 20 paroxetine (as hydrochloride) 20 mg tablet blister pack Ástralía - enska - Department of Health (Therapeutic Goods Administration)

extine 20 paroxetine (as hydrochloride) 20 mg tablet blister pack

arrotex pharmaceuticals pty ltd - paroxetine hydrochloride, quantity: 22.22 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; microcrystalline cellulose; mannitol; basic butylated methacrylate copolymer; titanium dioxide; purified talc; polyvinyl alcohol; sodium lauryl sulfate; glyceryl monostearate - treatment of major depression and for the prevention of relapse of depressive symptoms; treatment of obsessive compulsive disorder and for the prevention of relapse of ocd; treatment of panic disorder and for the prevention of relapse of panic disorder; treatment of social anxiety disorder/ social phobia; treatment of generalised anxiety disorder; and treatment of post-traumatic stress disorder

CILOPAM-S escitalopram (as oxalate) 5 mg tablet blister Ástralía - enska - Department of Health (Therapeutic Goods Administration)

cilopam-s escitalopram (as oxalate) 5 mg tablet blister

strides pharma science pty ltd - escitalopram oxalate, quantity: 6.37 mg (equivalent: escitalopram, qty 5 mg) - tablet, film coated - excipient ingredients: purified talc; microcrystalline cellulose; croscarmellose sodium; colloidal anhydrous silica; titanium dioxide; magnesium stearate; macrogol 400; hypromellose - treatment of major depression.,treatment of social anxiety disorder (social phobia).,treatment of generalised anxiety disorder.,treatment of obsessive-compulsive disorder.

PAROXETINE SANDOZ paroxetine (as hydrochloride) 20mg tablet blister pack Ástralía - enska - Department of Health (Therapeutic Goods Administration)

paroxetine sandoz paroxetine (as hydrochloride) 20mg tablet blister pack

sandoz pty ltd - paroxetine hydrochloride, quantity: 22.2 mg - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; mannitol; titanium dioxide; sodium starch glycollate; colloidal anhydrous silica; hypromellose; copovidone; purified talc - paroxetine sandoz is indicated for the treatment of : - major depression and for the prevention of relapse of depressive symptoms - obsessive compulsive disorder (ocd) and prevention of relapse of ocd - panic disorder and for the prevention of relapse of panic disorder - social anxiety disorder/social phobia - general anxiety disorder - post-traumatic stress disorder.

APX-PAROXETINE paroxetine (as hydrochloride) 20 mg tablet blister pack Ástralía - enska - Department of Health (Therapeutic Goods Administration)

apx-paroxetine paroxetine (as hydrochloride) 20 mg tablet blister pack

arrotex pharmaceuticals pty ltd - paroxetine hydrochloride, quantity: 22.22 mg (equivalent: paroxetine, qty 20 mg) - tablet, film coated - excipient ingredients: sodium starch glycollate; magnesium stearate; microcrystalline cellulose; mannitol; basic butylated methacrylate copolymer; titanium dioxide; purified talc; polyvinyl alcohol; sodium lauryl sulfate; glyceryl monostearate - treatment of major depression and for the prevention of relapse of depressive symptoms; treatment of obsessive compulsive disorder and for the prevention of relapse of ocd; treatment of panic disorder and for the prevention of relapse of panic disorder; treatment of social anxiety disorder/ social phobia; treatment of generalised anxiety disorder; and treatment of post-traumatic stress disorder

APX-ESCITALOPRAM escitalopram (as oxalate) 20 mg film-coated tablet blister pack Ástralía - enska - Department of Health (Therapeutic Goods Administration)

apx-escitalopram escitalopram (as oxalate) 20 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - escitalopram oxalate, quantity: 25.548 mg - tablet, film coated - excipient ingredients: maize starch; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; mannitol; titanium dioxide; hypromellose; macrogol 6000 - treatment of major depression. ,treatment of social anxiety disorder (social phobia). ,treatment of generalised anxiety disorder. ,treatment of obsessive-compulsive disorder.

APX-ESCITALOPRAM escitalopram (as oxalate) 10 mg film-coated tablet blister pack Ástralía - enska - Department of Health (Therapeutic Goods Administration)

apx-escitalopram escitalopram (as oxalate) 10 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - escitalopram oxalate, quantity: 12.774 mg - tablet, film coated - excipient ingredients: maize starch; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; mannitol; titanium dioxide; hypromellose; macrogol 6000 - treatment of major depression. ,treatment of social anxiety disorder (social phobia). ,treatment of generalised anxiety disorder. ,treatment of obsessive-compulsive disorder.

Betahistine dihydrochloride 8 mg Tablets Malta - enska - Medicines Authority

betahistine dihydrochloride 8 mg tablets

azure pharmaceuticals ltd 12 hamilton drive, the rock road, blackrock, co. louth a91 t997, ireland - tablet - betahistine dihydrochloride 8 mg - other nervous system drugs

Betahistine dihydrochloride 16 mg Tablets Malta - enska - Medicines Authority

betahistine dihydrochloride 16 mg tablets

azure pharmaceuticals ltd 12 hamilton drive, the rock road, blackrock, co. louth a91 t997, ireland - tablet - betahistine dihydrochloride 16 mg - other nervous system drugs

Betahistine dihydrochloride 24 mg Tablets Malta - enska - Medicines Authority

betahistine dihydrochloride 24 mg tablets

azure pharmaceuticals ltd 12 hamilton drive, the rock road, blackrock, co. louth a91 t997, ireland - tablet - betahistine dihydrochloride 24 mg - other nervous system drugs